This is a Validated Antibody Database (VAD) review about rhesus mac.. NGFR, based on 12 published articles (read how Labome selects the articles), using NGFR antibody in all methods. It is aimed to help Labome visitors find the most suited NGFR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (ME20.4)
  • flow cytometry; human; loading ...; fig 1f
BioLegend NGFR antibody (Biolegend, 345106) was used in flow cytometry on human samples (fig 1f). Cell Stem Cell (2019) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; loading ...; fig 1c
BioLegend NGFR antibody (BioLegend, 345114) was used in flow cytometry on human samples (fig 1c). elife (2019) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; loading ...; fig s5d
BioLegend NGFR antibody (Biolegend, 345110) was used in flow cytometry on human samples (fig s5d). Nature (2017) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; fig 2c
In order to report preclinical studies using a CRISPR-based methodology to target hematopoietic stem cells to treat beta-haemoglobinopathies, BioLegend NGFR antibody (BioLegend, ME20.4) was used in flow cytometry on human samples (fig 2c). Nature (2016) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; mouse; loading ...
In order to study the role of TMEM16F in limiting T cell responses in mice infected with virus, BioLegend NGFR antibody (BioLegend, 345108) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; loading ...; fig 7g
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend NGFR antibody (BioLegend, ME20.4) was used in flow cytometry on human samples (fig 7g). J Clin Invest (2016) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; fig 3
BioLegend NGFR antibody (Biolegend, 345104) was used in flow cytometry on human samples (fig 3). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (ME20.4)
BioLegend NGFR antibody (Biolegend, 345104) was used . Sci Rep (2016) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; loading ...; fig s7
BioLegend NGFR antibody (BioLegend, HE20.4) was used in flow cytometry on human samples (fig s7). Mol Ther Methods Clin Dev (2015) ncbi
mouse monoclonal (ME20.4)
  • immunohistochemistry; brown rat
BioLegend NGFR antibody (BioLegend, 345102) was used in immunohistochemistry on brown rat samples . J Anat (2015) ncbi
mouse monoclonal (ME20.4)
  • flow cytometry; human; fig 3
BioLegend NGFR antibody (Biolegend, ME20.4) was used in flow cytometry on human samples (fig 3). J Immunol (2015) ncbi
mouse monoclonal (ME20.4)
In order to investigate the roles of SCRG1 and BST1 to the self-renewal, migration, and osteogenic differentiation of human mesenchymal stem cells, BioLegend NGFR antibody (Biolegend, 345103) was used . Sci Rep (2014) ncbi
Articles Reviewed
  1. Vaidyanathan S, Salahudeen A, Sellers Z, Bravo D, Choi S, Batish A, et al. High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia. Cell Stem Cell. 2019;: pubmed publisher
  2. Naamati A, Williamson J, Greenwood E, Marelli S, Lehner P, Matheson N. Functional proteomic atlas of HIV infection in primary human CD4+ T cells. elife. 2019;8: pubmed publisher
  3. Shaffer S, Dunagin M, Torborg S, Torre E, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546:431-435 pubmed publisher
  4. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed publisher
  5. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  6. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  7. Camilleri E, Gustafson M, Dudakovic A, Riester S, Garces C, Paradise C, et al. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016;7:107 pubmed publisher
  8. Nakatsugawa M, Rahman M, Yamashita Y, Ochi T, Wnuk P, Tanaka S, et al. CD4(+) and CD8(+) TCR? repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep. 2016;6:23821 pubmed publisher
  9. Lin H, Masaki H, Yamaguchi T, Wada T, Yachie A, Nishimura K, et al. An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils. Mol Ther Methods Clin Dev. 2015;2:15046 pubmed publisher
  10. Zilic L, Garner P, Yu T, Roman S, Haycock J, Wilshaw S. An anatomical study of porcine peripheral nerve and its potential use in nerve tissue engineering. J Anat. 2015;227:302-14 pubmed publisher
  11. Nakatsugawa M, Yamashita Y, Ochi T, Tanaka S, Chamoto K, Guo T, et al. Specific roles of each TCR hemichain in generating functional chain-centric TCR. J Immunol. 2015;194:3487-500 pubmed publisher
  12. Aomatsu E, Takahashi N, Sawada S, Okubo N, Hasegawa T, Taira M, et al. Novel SCRG1/BST1 axis regulates self-renewal, migration, and osteogenic differentiation potential in mesenchymal stem cells. Sci Rep. 2014;4:3652 pubmed publisher